Global Apheresis Market Projected to Reach USD 4.41 Billion by 2031

Industry
โดย GlobeNewswire·Read original
Summary · why it matters

The global apheresis market is projected to grow from USD 3.02 billion in 2026 to USD 4.41 billion by 2031, at a compound annual growth rate of 7.9%. Disposables hold the largest product share, driven by recurring demand from blood collection and therapeutic procedures. Plasmapheresis leads by procedure, supported by rising demand for plasma-derived therapies and increasing plasma donations. North America maintained the largest regional market share in 2025, reflecting high disease prevalence and broad adoption of apheresis technologies. Key players include Terumo Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, and Becton, Dickinson and Company.

Impact on stocks 4

Health Care▲ · 2 stocks
Terumo Corporation
4543
▲ PositiveDemandrelevance

Terumo is a key player in apheresis, benefiting from projected market growth.

Biotech & Genomic Medicine▲ · 2 stocks
Haemonetics Corporation
HAE
▲ PositiveDemandrelevance

Haemonetics is a key player in apheresis, benefiting from projected market growth.

© 2026 MarketDXNews